Cumberland Pharmaceuticals (CPIX) EPS (Basic) Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.41 Mn | 112.54 Mn | - | -89.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -48.94% |
| Mar 31, 2026 | -169.16% |
| Dec 31, 2024 | -81.76% |
| Sep 30, 2024 | -74.09% |
| Jun 30, 2024 | -63.18% |
| Mar 31, 2024 | -82.51% |
| Dec 31, 2023 | -112.99% |
| Sep 30, 2023 | -51.09% |
| Jun 30, 2023 | 7.32% |
| Mar 31, 2023 | -39.32% |
| Dec 31, 2021 | 27.81% |
| Sep 30, 2021 | 32.24% |
| Jun 30, 2021 | 39.25% |
| Mar 31, 2021 | 30.39% |
| Dec 31, 2020 | 46.02% |
| Sep 30, 2020 | 45.45% |
| Jun 30, 2020 | 29.06% |
| Mar 31, 2020 | 252.86% |
| Dec 31, 2019 | 74.17% |
| Sep 30, 2019 | 146.14% |